A Meta ‐analysis of Arrhythmia Endpoints in Randomized Controlled Trials of Transendocardial Stem Cell Injections for Chronic Ischemic Heart Disease

ConclusionNon ‐skeletal myoblast transendocardial cell therapy was associated with a significantly lower risk of SCD or resuscitated SCA compared to control, with no proarrhythmic effects.This article is protected by copyright. All rights reserved.

Source: Journal of Cardiovascular Electrophysiology - September 18, 2019 Category: Cardiology Authors: Gilson C. Fernandes, Amanda D. F. Fernandes, Manuel Rivera, Aisha Khan, Ivonne H. Schulman, Litsa K. Lambrakos, Robert J. Myerburg, Jeffrey J. Goldberger, Joshua M. Hare, Raul D. Mitrani Tags: ORIGINAL ‐ CLINICAL Source Type: research